NCX 905

Drug Profile

NCX 905

Alternative Names: Timolol-NO

Latest Information Update: 16 Aug 2002

Price : $50

At a glance

  • Originator NicOx
  • Class Antiglaucomas
  • Mechanism of Action Beta-adrenergic receptor antagonists; Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Glaucoma

Most Recent Events

  • 02 May 2000 New profile
  • 02 May 2000 Preclinical development for Glaucoma in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top